Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000082

Director acquired 12,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stalfort John A III Director 2025-06-04 Grant or award +12,800 185,124 D
Derivatives
Stalfort John A III Director 2025-06-04 Grant or award · Stock Option (right to buy) +19,500 19,500 D
Loading xslF345X05/wk-form4_1749157011.xml…